Lantern Pharma (LTRN)Director bought ~$100K
D Jeffrey Keyser, Director at Lantern Pharma, bought ~$100K of Lantern Pharma shares.
- ~$100K
- Approx. value · 49K sh @ $2.06
- 94K
- Holds after · shares reported
- Traded
- May 12, 2026
- Filed
- May 14, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 30, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- May 12, 2026 · this disclosureInsider · 3 days before resultsDirector purchased ~$100K of LTRN shares in the open market
What came next
- May 12, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
- May 12, 2026Insider · 3 days before resultsDirector purchased ~$100K of LTRN shares in the open market
- May 15, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 14, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Lantern Pharma
OQRO holds no insider, Congress, fund or contract record for Lantern Pharma dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LTRN page.
How this filing works
Other disclosures at Lantern Pharma
- SEC Form 4May 14, 2026
- SEC Form 4Jun 13, 2025
- SEC Form 4Jun 13, 2025
- SEC Form 4Jun 13, 2025
- SEC Form 4Jun 13, 2025
- SEC Form 4Jun 13, 2025
Everything OQRO holds on this company is on its LTRN page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data